Literature DB >> 33190479

Probing the Mechanism of Hepatotoxicity of Hexabromocyclododecanes through Toxicological Network Analysis.

Weina Dai1, Tiantian Tang1, Zhenghua Dai1,2, Da Shi3, Lingyun Mo4,5, Yonghong Zhang1.   

Abstract

The prediction and mechanism analysis of hepatotoxicity of contaminants, because of their various phenotypes and complex mechanisms, is still a key problem in environmental research. We applied a toxicological network analysis method to predict the hepatotoxicity of three hexabromocyclododecane (HBCD) diastereoisomers (α-HBCD, β-HBCD, and γ-HBCD) and explore their potential mechanisms. First, we collected the hepatotoxicity related genes and found that those genes were significantly localized in the human interactome. Therefore, these genes form a disease module of hepatotoxicity. We also collected targets of α-, β-, and γ-HBCD and found that their targets overlap with the hepatotoxicity disease module. Then, we trained a model to predict hepatotoxicity of three HBCD diastereoisomers based on the relationship between the hepatotoxicity disease module and targets of compounds. We found that 593 genes were significantly located in the hepatotoxicity disease module (Z = 11.9, p < 0.001) involved in oxidative stress, cellular immunity, and proliferation, and the accuracy of hepatotoxicity prediction of HBCD was 0.7095 ± 0.0193 and the recall score was 0.8355 ± 0.0352. HBCD mainly affects the core disease module genes to mediate the adenosine monophosphate-activated kinase, p38MAPK, PI3K/Akt, and TNFα pathways to regulate the immune reaction and inflammation. HBCD also induces the secretion of IL6 and STAT3 to lead hepatotoxicity by regulating NR3C1. This approach is transferable to other toxicity research studies of environmental pollutants.

Entities:  

Year:  2020        PMID: 33190479     DOI: 10.1021/acs.est.0c03998

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  3 in total

1.  Update of the risk assessment of hexabromocyclododecanes (HBCDDs) in food.

Authors:  Dieter Schrenk; Margherita Bignami; Laurent Bodin; James Kevin Chipman; Jesús Del Mazo; Bettina Grasl-Kraupp; Christer Hogstrand; Laurentius Ron Hoogenboom; Jean-Charles Leblanc; Carlo Stefano Nebbia; Elsa Nielsen; Evangelia Ntzani; Annette Petersen; Salomon Sand; Tanja Schwerdtle; Heather Wallace; Diane Benford; Peter Fürst; Martin Rose; Sofia Ioannidou; Marina Nikolič; Luisa Ramos Bordajandi; Christiane Vleminckx
Journal:  EFSA J       Date:  2021-03-08

2.  Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways.

Authors:  Dan Li; Ying-Ying Guo; Xian-Feng Cen; Hong-Liang Qiu; Si Chen; Xiao-Feng Zeng; Qian Zeng; Man Xu; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2021-12-16       Impact factor: 7.169

3.  iMS2Net: A multiscale networking methodology to decipher metabolic synergy of organism.

Authors:  Jiyang Dong; Qianwen Peng; Lingli Deng; Jianjun Liu; Wei Huang; Xin Zhou; Chao Zhao; Zongwei Cai
Journal:  iScience       Date:  2022-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.